PREDICTORS OF DISEASE FLARE AFTER DISCONTINUATION OF CONCOMITANT METHOTREXATE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB

被引：0
|
作者：
Asai, S. [1 ]
Takahashi, N. [1 ]
Kuwatsuka, Y. [2 ]
Ando, M. [2 ]
Ishiguro, N. [1 ]
Kojima, T. [1 ]
机构：
[1] Nagoya Univ, Dept Orthoped Surg, Grad Sch Med, Nagoya, Aichi, Japan
[2] Nagoya Univ Hosp, Dept Adv Med, Nagoya, Aichi, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1095
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0088
引用
收藏
页码：252 / 253
页数：2
相关论文
共 50 条
  • [31] Should rheumatoid arthritis patients preferentially be treated with tocilizumab after rituximab failure?
    Verschueren, Patrick
    RHEUMATOLOGY, 2016, 55 (02) : 197 - 198
  • [32] THE INCIDENCE AND PREDICTORS OF FLARE IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS
    Rutherford, Andrew I.
    Scott, David L.
    Subesinghe, Sujith
    Ibrahim, Fowzia
    Galloway, James
    RHEUMATOLOGY, 2016, 55 : 73 - 73
  • [33] Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
    Rubbert-Roth, Andrea
    Sebba, Anthony
    Brockwell, Laura
    Kelman, Ariella
    Porter-Brown, Benjamin
    Pulley, Jennifer
    Napalkov, Pavel
    van Vollenhoven, Ronald F.
    RMD OPEN, 2016, 2 (01):
  • [34] INCIDENCE OF MELANOMA IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB
    Gale, S.
    Wang, J.
    Nebesky, J. M.
    Linke, A. T.
    Berber, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 579 - 579
  • [35] PREGNANCY OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Ishikawa, H.
    Kaneko, A.
    Hattori, Y.
    Takahashi, N.
    Kida, D.
    Sato, T.
    Osawa, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 501 - 502
  • [36] Risk of infections in rheumatoid arthritis patients treated with tocilizumab
    Lang, Veronika R.
    Englbrecht, Matthias
    Rech, Juergen
    Nuesslein, Hubert
    Manger, Karin
    Schuch, Florian
    Tony, Hans-Peter
    Fleck, Martin
    Manger, Bernhard
    Schett, Georg
    Zwerina, Jochen
    RHEUMATOLOGY, 2012, 51 (05) : 852 - 857
  • [37] SUSTAINED RESPONSE FOLLOWING DISCONTINUATION OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL (COMP-ACT)
    Kremer, J.
    Rigby, W.
    Singer, N.
    Birchwood, C.
    Gill, D.
    Reiss, W.
    Pei, J.
    Michalska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 567 - 568
  • [38] Pancytopenia in rheumatoid arthritis patients treated with methotrexate
    Laroche, F
    Perrot, S
    Menkes, CJ
    PRESSE MEDICALE, 1996, 25 (25): : 1144 - 1146
  • [39] Impact of Concomitant Methotrexate on Disease Activity After Tapering Abatacept in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
    Park, Jun Won
    Kim, Min Jung
    Kim, Hyoun-Ah
    Kim, Jin Hyun
    Shin, Kichul
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5049 - 5050
  • [40] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
12345